The NanoBio&Med 2023 International Conference: Exploring Advances in Nanobiotechnology and Nanomedicine 

The NanoBio&Med 2023 International Conference, held last week at the Barcelona Science Park (PCB) from November 21 to 23, has marked a milestone by presenting the latest developments in the fields of nanobiotechnology and nanomedicine. 

The event, in its eleventh edition and organized by the PHANTOMS Foundation, once again had the collaboration of the Catalonia Institute of Bioengineering (IBEC) and establishes itself as the annual meeting to forge new collaborations and drive innovative projects in the scientific-industrial sector. 

During the conference, emerging and future trends in nanotechnology, biotechnology, and medicine were addressed. Industry experts, academics, and institutions participated in substantial discussions on advances, challenges, and recent progress in these interdisciplinary areas. 

The conference fostered constructive dialogue between business and public leaders, focusing specifically on technologies and applications in the biomedical sector. 

The event, inaugurated by Josep Samitier, director of IBEC and one of the coordinators of the event, also featured presentations by Samuel Sánchez, ICREA research professor at IBEC and principal investigator of the Smart nanobio devices group, who presented his latest work on bladder cancer treated with nanorobots; César Rodriguez-Emmenegger, ICREA research professor and principal investigator of the Bioinspired interactive materials and protocellular systems group, who presented his work on the design of biointerfaces and synthetic cells for nanomedicine, and Giuseppe Battalia, ICREA research professor and principal investigator of the Molecular bionics group, who focused on his work on targeted transport of macromolecules to treat Alzheimer’s disease. 

In parallel sessions, Christopher James, researcher in the Biomaterials for regenerative therapies group; Aurora Dols Perez, researcher in the Nanoscale Bioelectrical Characterization group; Barbara Borges Fernandes, and Lara Victoria Aiassa, both from the Molecular bionics group, also participated. 

This event is organized by the PHANTONS Foundation, the Institute for Bioengineering of Catalonia (IBEC), the Catalan Institute of Nanoscience and Nanotechnology (ICN2), the University of Natural Resources and Life Sciences in Vienna (BOKU) and the Spanish Platform for Nanomedicine (NanomedSpain), which brings together nearly 200 organizations including hospitals, research centers, companies, technology centers and observers. 

Once again, the success of NanoBio&Med 2023 sets the foundation for the anticipated next edition, NanoBio&Med 2024, scheduled for November 5-7, emerging as the epicenter to gain a comprehensive understanding of the state of the art in nanobiotechnology and nanomedicine, as well as to learn about the latest research and innovative results.